A new study suggests a recently approved drug for advanced pancreatic cancer may also be effective against lung cancer. The drug, which has shown promise in treating pancreatic cancer, is being explored for its potential in treating another type of cancer. Further research is needed to confirm the findings, but the early study indicates the drug may have applications beyond its initial approval.

Details of the study and its results are available for those seeking more information. The potential for a new treatment option is significant, and ongoing research will be important in determining the drug's effectiveness against lung cancer.